Queen s University researchers looking at new method of detecting cancer trentonian.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trentonian.ca Daily Mail and Mail on Sunday newspapers.
Author of the article: The Whig-Standard
Publishing date: Jun 25, 2021 • 14 hours ago • 2 minute read • Christopher Mueller, lead author of a new study that looks at a new method to help detect metastatic breast cancer. Mueller is the principal investigator, Division of Cancer Biology and Genetics, Queen s Cancer Research Institute and Professor of Biomedical and Molecular Sciences and Pathology and Molecular Medicine, Queen s University. Supplied photo Photo by Queen s University /supplied photo
Article content
KINGSTON – A team of researchers at Queen’s University has helped develop a new, cost-effective cancer detection and characterization method, based on the presence of circulating tumour DNA in the blood called mDETECT (methylation DETEction of Circulating Tumour DNA).
Queen s University researchers looking at new method of detecting cancer pembrokeobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pembrokeobserver.com Daily Mail and Mail on Sunday newspapers.
May 14, 2021, by NCI Staff
Cells go through stages of the cell cycle to grow and divide. Specific proteins keep that cycle from spiraling out of control. New research shows that loss of the AMBRA1 protein can lead to uncontrolled cell growth.
Credit: BruceBlaus, Wikimedia Commons, CC BY-SA 4.0
At the heart of all cancers is a fundamental problem: a cell and eventually innumerable cells that won’t stop dividing. This runaway growth is what forms a tumor, and the abnormal cellular processes that drive this growth can help tumors withstand the cancer treatments intended to kill them.
Despite more than six decades of research into the mechanisms that cells use to divide, some of the nuts and bolts of the process remain a mystery. Scientists want to better understand these mechanisms in hopes of targeting them and potentially shutting down the uncontrolled growth of some tumors.
MetroHealth forms Center for Cancer Research
Print
A newly formed MetroHealth Center for Cancer Research brings together nationally and internationally recognized researchers to focus on more than curing one of the most feared diseases.
Backed by millions of dollars in support and grants and dozens of research assistants, the team will also focus on ending racial, ethnic, social and economic inequities that impact cancer diagnosis and treatment, according to a news release. We re doing this for the patients we serve, to ensure that they have the latest advances in cancer care and that they are able to participate in cutting-edge clinical trials in cancer care, said Dr. Bernard Boulanger, MetroHealth s executive vice president and chief clinical officer, in a provided statement.